AJRD

ANALYST NOTE: AJRD (Aerojet Rocketdyne Holdings, Inc.) Date: 2026-06-13 Current Price: $57.99

1. Structural Readiness

State: Context-only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 1.0% (Sub-threshold)

Analysis: As of the close on 2026-06-13, the structural setup for AJRD is not defined. The provided data indicates a "context-only" state with no active, forming, or invalidated coil structure recorded.

• Volatility Context: The current ATR of 1.0% is sub-threshold (<2.5%), indicating low volatility. In the StoryStocks framework, this suggests the stock is currently in a consolidation or low-momentum phase, but without a defined pivot structure, this low volatility does not constitute a "forming coil" signal. It is simply a lack of structural definition.

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED Macro Thesis: None.

There is no named secular thesis attached to AJRD as of this date. The investment case is strictly tactical and setup-led. We are not evaluating this name based on a macro narrative (e.g., "Space Economy Boom" or "Hypersonic Dominance") but rather on the quality of its current business fundamentals and the potential for a structural setup to form. The conviction must be derived entirely from the operational evidence provided and the eventual formation of a technical structure, not from an external thematic overlay.

3. Business Fundamentals (As of 2026-06-13)

Company Profile: Aerojet Rocketdyne Holdings, Inc. is an American enterprise focused on the creation, production, and distribution of advanced aerospace and defense solutions. The company operates through two distinct segments:

• Aerospace and Defense: A key supplier to the U.S. government (DoD, NASA) and prime contractors. This segment provides liquid and solid rocket propulsion, air-breathing hypersonic engines, electric power systems, and armament systems.
• Real Estate: Manages non-core land assets, including a substantial parcel of 11,277 acres east of Sacramento, California, involving re-zoning, entitlements, and sales/leases.

Operational Evidence & Management Expectations (Source: 2022-11-01 Earnings Transcript): While the most recent earnings transcript in the evidence base is dated 2022-11-01, the company profile cache confirms these operations remain active as of 2026-06-12. The historical data provides the following baseline for the business model:

• Backlog Health: Management previously reported a backlog of $6.7 billion, described as "healthy" and equal to approximately three times annual sales. The book-to-bill ratio was 0.9 for the first nine months of the prior year.
• Production Capacity: Management stated they were "on target" to substantially increase annual production capacity, including the opening of a second production facility.
• Revenue Mix: RS-25 sales were trending upward, moving from 13% to 15% of sales in the second and third quarters, with management expecting this trend to continue.
• Strategic Wins: The company was selected to power the Navy's Compact, Rapid Attack Weapon (CRAW) and provided critical propulsion elements for the Artemis 1 mission (SLS and Orion).
• Long-term Guidance: Management identified hypersonics as a national priority, expecting it to contribute 5% to 10% of total sales over the long run.
• Financial Targets: Management expressed confidence in hitting revenue and adjusted EBITDA targets for the year (excluding EAC adjustments).

Gap in Evidence: There is a significant gap in the evidence base regarding 2023–2026 financial performance. The most recent earnings transcript is from 2022. We do not have current data on the 2026 backlog size, current revenue run-rate, or whether the "substantial increase in production capacity" mentioned in 2022 has been fully realized or if new bottlenecks have emerged. The 2026 company profile confirms the business segments exist but does not provide updated financial metrics.

4. Archetype and Conviction

Archetype: Growth Leader (Layer A Classification) Fit Analysis: The name fits the Growth Leader archetype based on its historical positioning as a preferred supplier for national defense and space systems, with a backlog historically three times annual sales. The business model relies on high-barrier-to-entry technology (hypersonics, RS-25 engines) and government contracts, which typically supports a growth narrative.

Conviction Stack:

• Thesis Strength: Low (No named macro thesis; purely tactical).
• Evidence Quality: Mixed. The business description is robust, but the financial evidence is dated (2022). The 2026 profile confirms the business model but lacks the "spine" of current financials (revenue, margins, backlog updates).
• Structural Quality: Null. No setup is defined. The ATR of 1.0% is sub-threshold, indicating a lack of momentum or volatility required for a high-conviction setup.
• Setup Readiness: None. The setup is not forming, confirmed, or invalidated. It is a "context-only" observation.
• Rerating Potential: Unknown. Without a breakout structure or updated financial growth data, rerating potential cannot be quantified.

Valuation Context: No valuation metrics (P/E, EV/EBITDA, etc.) are provided in the evidence base for 2026. Therefore, no valuation context can be applied.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Updated Financials: Release of 2023–2026 earnings data confirming the backlog remains healthy (e.g., >$6.7B) and that the production capacity expansion has led to margin expansion.
• Volatility Expansion: An increase in ATR above the 2.5% threshold would signal the market is re-rating the stock, moving it out of the "sub-threshold" zone.

What Would Invalidate the Case:

• Backlog Erosion: If current data showed the backlog had fallen significantly below the 3x annual sales ratio, the "Growth Leader" thesis would be structurally compromised.
• Contract Loss: Loss of major DoD or NASA contracts (e.g., CRAW, Artemis successors) would be a material negative.

Honest Gaps in Evidence:

• Missing Financial Data: The most critical gap is the lack of financial data from 2023 through 2026. We are analyzing a 2026 price point using 2022 earnings transcripts.
• Missing Technical Structure: There is no data on the current price action relative to moving averages, pivot levels, or volume profiles.
• Missing Sector Context: The sector and industry classification are not provided, making relative strength analysis impossible.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key evidence: Backlog historically healthy at $6.7B (3x annual sales); RS-25 sales trending up; Selected for Navy CRAW and Artemis 1 missions. Key risks: No current financial data (evidence gap from 2022 to 2026); No defined technical setup (ATR sub-threshold); No named macro thesis. Sizing hint: Position size should be zero until a structural setup forms or updated financials are released. Expected path: Management expectations for production capacity expansion and hypersonic growth (5-10% of sales) remain the primary drivers, but current price action is dormant. Expected horizon: Indefinite until structural setup forms or earnings data is updated.